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ieoatherosclerosis (1) is characterized by
infiltration of foamy macrophage clusters
within neoimtima, and thin-capped neo-
atheroma (TCNA) and neointimal rupture
has been demonstrated during an extended period as a
contributor to late stent failure (2–4). Using intravas-
cular ultrasound (IVUS) and optical coherence to-
mography (OCT), we characterized in-stent resteno-
sis (ISR) in patients who underwent clinically driven
target lesion revascularization late after bare-metal
stent (BMS) placement. FromMarch 2009 to August
2011, 51 patients with BMS-ISR underwent target
lesion revascularization; 30 patients presented with
stable and 21 with unstable angina. Of the 30 patients
with stable angina, 26 (87%) had demonstrated thal-
lium scan perfusion defects of target vessel territories,
and 4 (13%) showed resting or exercise-induced ST-
segment–T-wave changes on electrocardiography.
Pre-procedure OCT was performed in 22 of 51
patients, using a 0.019-inch ImageWire (LightLab
Imaging, Westford, Massachusetts). OCT findings
were classified as calcific intima, lipid-rich intima,
TCNA, neointimal rupture, and thrombi, and were
defined as previously described (4). IVUS imaging was
performed after OCT imaging; lesions were stented,
and reference segments were analyzed.
In the 22 patients undergoing OCT imaging
(Table 1), unstable angina patients showed a trend of
a thinner fibrous cap compared with stable angina
patients (50 m [interquartile range (IQR): 40 to 60
m] vs. 60 m [IQR: 50 to 120 m], p  0.056).
Overall, 15 (68%) lesions had at least 1 TCNA;
multiple TCNA were seen in 7 (32%) lesions. Neo-
intimal rupture was identified in 13 (59%) lesions, and
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relevant to the contents of this paper to disclose.ultiple neointimal ruptures were present in 5 (23%)
esions. At the site of the minimal lumen area (MLA),
he frequency of TCNA and neointimal rupture was
5% and 46%, respectively. The frequency of these
ndings was 46% and 32% at the proximal segment to
he MLA site, and 18% and 5% at the distal segment
f theMLA site, respectively. Red thrombi were more
requent in patients with unstable angina compared
ith stable angina (75% vs. 30%, p  0.035). All
esions but 1 (95%) showed at least 1 of the 3 OCT
ndings, that is, TCNA, neointimal rupture, and
eointimal thrombi; 11 (50%) patients had all 3, and
9 (86%) had 2 of these features. All but 1 lesion
92%) with OCT-defined rupture had thrombi near
he rupture site. The rate of agreement between
rayscale IVUS and OCT for detecting neointimal
upture was 59% and for detecting thrombus was 41%.
Therefore, the present study demonstrates OCT-
erified neointimal thrombi in 80%, TCNA in 70%,
nd neointimal rupture in 60% ISR, and suggests that
dvanced neoatherosclerosis is a common mechanism
f very late BMS-ISR. Takano et al. (3) reported
ifferent OCT findings of BMS-ISR between late
SR beyond 5 years and early ISR within 6 months.
he frequency of lipid-rich neointima (67% vs. 0%),
eointimal disruption (38% vs. 0%), and TCNA (29%
s. 0%) was substantially higher in the late-phase ISR.
abara et al. (5) also suggested that the frequency of
eointimal rupture with cavity formation and intralu-
inal material was only 19% and 21%, respectively, in
he very late BMS-ISR 5 years. We observed a
igher frequency of TCNA (68%), neointimal rupture
59%), and neointimal thrombi (77%). Nakazawa
t al. (1) suggested that the earliest atherosclerotic
hange in BMS remained rare until 4 years, and
ecrotic core formation began from 5 years after
mplantation. Because the incidence and severity of
eoatherosclerosis is time dependent, the difference
2ﬁbroatherom
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1268in stent duration and characteristics of the patient
population may explain the discrepancy in neointi-
mal composition among the studies. Most reports
have included lesions without ISR or lesions with
incidentally detected ISR during routine angio-
US-OCT Analysis
Variable Total (N  51)
OCT Subgroup
(n  22)
asured MSA, mm2 6.6 (5.2–8.2) 7.0 (5.4–7.6)
asured MLA, mm2 2.0 (1.4–2.5) 1.5 (1.3–2.5)
ea at the MLA site, mm2 8.1 (6.2–10.0) 8.5 (7.0–9.5)
rea at the MLA site, mm2 15.9 (13.3–18.7) 16.2 (13.0–18.4)
74.3 (64.7–81.5) 77.1 (70.2–84.3)
nt IH at the MLA site 45 (88%) 22 (100%)
pansion at the MLA site 17 (33%) 5 (23%)
pansion in entire
gment
27 (53%) 10 (46%)
ﬁned intimal rupture 22 (43%) 12 (55%)
ﬁned thrombi 13 (26%) 8 (36%)
verage
letely embedded at all
mes
20 (90%)
position seen at 1
me
1 (5%)
asured MLA, mm2 1.6 (1.0–2.4)
ea at the MLA site, mm2 9.0 (7.9–11.2)
eointima 22 (100%)
-containing 7 (32%)
s of ﬁbrous cap, m 50 (50–60)
ned intimal rupture 13 (59%)
ntaining neointima 15 (68%)
ned thrombi 17 (77%)
ned red thrombi 12 (55%)
edian (interquartile range [IQR]) or n (%). Continuous variables were compared
arametric Mann-Whitney test, and categorical variables were compared by
tatistics or Fisher exact test. Signiﬁcant IH is deﬁned as %IH/stent area 50%.
sion is deﬁned as MSA 7.0 mm2.
al hyperplasia; IVUS  intravascular ultrasound; MLA  minimal lumen area;
imal stent area; OCT  optical coherence tomography; TCFA  thin-cap
a.metal and drug-eluting stents. J Am
Coll Cardiol 2011;57:1314–22.
3
4
lation 2011;123:2954was 132.0 31.2 months, which is longer than that
in the studies by Takano et al. (3) (91.5  25.9
months) and Habara et al. (5) (113.8 29.6 months)
(3,5). Moreover, target lesion revascularization was
performed in only 62% of patients in the former and
72% of patients in the latter study, wherein 40% of
patients were asymptomatic. Our study only in-
cluded symptomatic patients with clinically driven
target lesion revascularization. Furthermore, in our
case, the patients presented either with unstable an-
gina or stable angina with objective evidence of myo-
cardial ischemia. Frequent calcium-containing neoin-
tima (32%) supported our contention that the patients
were at more advanced stages of neoatherosclerosis
and restenotic progression. Unstable neointima includ-
ing TCNA, neointimal rupture, and neointimal thrombi
were common even in patients with stable presentation.
The neoatherosclerotic process may promote further
luminal narrowing or develop an unstable substrate dur-
ing the delayed phase.
The data in this paper does have certain distinct
limitations. First, because this study included only
patients with clinically driven target lesion revascu-
larization, it is difficult to determine the incidence
of major findings in an unselected population.
Second, by not performing serial imaging follow-
up, we could not determine the natural course of
BMS-treated lesions and predictors of neoathero-
sclerosis. Third, because attenuation caused by red
thrombi obscured underlying morphology, we may
have underestimated the frequency of some OCT
findings. In conclusion, OCT findings of vulnerable
neointima were frequent in patients with very late
BMS-ISR, suggesting that neoatherosclerosis is a
general mechanism of late BMS failure.
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